The Safety and Efficacy of Transconjunctival Sutureless 23-gauge Vitrectomy by Kim, Moon Jung et al.
Korean Journal of Ophthalmology 21(4):201-207, 2007
DOI : 10.3341/kjo.2007.21.4.201
201
The Safety and Efficacy of Transconjunctival Sutureless 
23-gauge Vitrectomy
Moon Jung Kim, MD,
1,2 Kyu Hyung Park, MD,
1-3  Jeong-Min Hwang, MD,
1-3
Hyung Gon Yu, MD,
1,2 Young Suk, Yu, MD,
1,2 Hum Chung, MD
1,2
Department of Ophthalmology, Seoul National University College of Medicine
1, Seoul, Korea
Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute
2, Seoul, Korea
Seoul National University Bundang Hospital
3, Seoul, Korea
Purpose: To evaluate the efficacy and safety of vitreoretinal surgery using a 23-gauge transconjunctival 
sutureless vitrectomy (TSV) system for various vitreoretinal diseases. 
Methods: A retrospective, consecutive, interventional case series was performed for 40 eyes of 40 patients. 
The patients underwent vitreoretinal procedures using the 23-gauge TSV system, including idiopathic 
epiretinal membrane (n=7), vitreous hemorrhage (n=11), diabetic macular edema (n=10), macular hole (n=5), 
vitreomacular traction syndrome (n=5), diabetic tractional retinal detachment (n=1), and rhegmatogenous 
retinal detachment (n=1). Best corrected visual acuity (BCVA), intraocular pressure (IOP), and intra- and 
post-operative complications were evaluated.  
Results: Intraoperative suture placement was necessary in 3 eyes (7.5%). The median BCVA improved 
from 20/400 (LogMAR, 1.21±0.63) to 20/140 (LogMAR, 0.83±0.48) at 1 week (p=0.003), 20/100 (LogMAR, 
0.85±0.65) at 1 month (p=0.002), 20/100 (LogMAR, 0.73±0.6) at 3 months (p=0.001). In 1 eye, IOP was 
5 mmHg at 2 hours and 4 mmHg at 5 hours, but none of the eyes showed hypotony after 1 postoperative 
day. No serous postoperative complications were observed during a mean follow-up of 8.4±3.4 months 
(range 3-13 months) 
Conclusions: The 23-gauge TSV system shows promise as an effective and safe technique for a variety 
of vitreoretinal procedures. It appears to be a less traumatic, more convenient alternative to 20-gauge 
vitrectomy in some indications.
Korean Journal of Ophthalmology 21(4):201-207, 2007
Key Words: Retina, Sutureless vitrectomy, Vitreous
Received: June 11, 2007    Accepted: October 30, 2007
Reprint request to Kyu Hyung Park, MD. Department of Ophthal- 
mology, Seoul National University Bundang Hospital. 300 Gumi-dong, 
Bundang-gu, Seongnam, Gyunggi-do 463-707, Korea. Tel: 82-31-787- 
7373, Fax: 82-31-787-4057, E-mail: jiani4@snu.ac.kr
Since Fujii et al
1,2 introduced 25-gauge transconjunctival 
sutureless vitrectomy (TSV) in 2002, it has been used in 
treating uncomplicated vitreoretinal diseases with sutureless 
vitrectomy.
Owing to the small incision and lack of suture, 25-gauge 
TSV enables minimization of surgical trauma, removal of 
suture related inflammation, and faster postoperative recovery. 
However, many vitreoretinal surgeons use it only in limited 
indications due to the inborn high flexibility of 25-gauge 
instruments. TSV with 23-gauge, introduced by Eckardt in 
2005,
3 offers a firmer instrument and supports easier use by 
the vitreous surgeon who is more familiar with the 20-gauge 
intrument rather than the 25-gauge instrument. This 
advantage may help the surgeon converting from 20-gauge 
vitrectomy to TSV. Even though its use is increasing, the 
efficacy and complications of 23-gauge TSV has not yet been 
determined due to the very recent introduction. To elucidate 
these aspects, we report our initial experience of 40 eyes of 
40 patients who were treated with 23-gauge TSV to evaluate 
the surgical outcome and its complications. 
Materials and Methods
Patients
We retrospectively reviewed the medical records of the 40 
eyes of 40 patients who underwent 23-gauge TSV by single 
surgeon from June 2005 till March 2006. All patients gave 
their informed consent prior to their inclusion in the study 
and Institutional Ethics Committee was granted for the study. 
The indications for vitrectomy were idiopathic epiretinal 
membrane (7 eyes), vitreous hemorrhage (11 eyes), diabetic Kor J Ophthalmol Vol.21, No.4, 2007
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macular edema (10 eyes), macular hole (5 eyes), 
vitreomacular traction syndrome (5 eyes), diabetic tractional 
retinal detachment (1 eye), and rhegmatogenous retinal 
detachment (1 eye) (Table 1). Complicated cases such as 
severe proliferative vitreoretinopathy (PVR), severe diabetic 
tractional detachment, expected silicone oil injection, trauma 
and intraocular foreign body were not included in this study.
Surgical method
Surgery with 23-gauge TSV was performed by the same 
method and instruments suggested by Eckardt. Briefly, the 
conjunctiva was displaced about 2 mm laterally using a 
specially designed pressure plate (DORC, Zuidland, Holland) 
and hold the eye firmly. A 15 to 30° angled tunnel incision 
which was parallel to the limbus, and was made through the 
conjunctiva, sclera, and pars plana 3.5 mm from the 
corneoscleral limbus a with 23-gauge stiletto blade (45° 
angle; BD Medical-Ophthalmic Systems, Franklin Lakes, NJ). 
The microcannula was then inserted through the tunnel 
incision already made using a specially designed, blunt 
inserter (DORC, Zuidland, Holland). Twenty three-gauge 
instruments such as vitrectomy probe, microscissors, forceps, 
endolaser probe, endodiathermy probe, and flute needle were 
used for vitrectomy. A pneumatic vitreous cutter was used 
with a vitrectomy unit (Accurus, Alcon Surgical, Texas, 
USA). Fluid gas exchange was performed in 9 eyes. 
Combined cataract extraction through clear corneal incision 
performed in 23 eyes. Patients with idiopathic macular hole 
underwent internal limiting membrane peeling. At the end of 
the surgery, the microcannulas were withdrawn using 
specially designed, cannular forceps (DORC, Zuidland, 
Holland) from scleral tunnel incision without suturing of the 
sclera and conjunctiva. Gentle pressing with cotton tip 
applicator was applied on the sclerotomy site to enhance 
sealing of sclerotomy and return the displaced conjunctive to 
its original position. If there was subconjunctival hemorrhage 
at the incision site, gentle pressure using a cotton tip 
applicator over the bleeding site was applied till the 
homeostasis occurred. Only 2 cases required diathermy 
through the previous conjunctival opening. Suture was 
applied at the sclerotomy site if any sign of leakage was 
found such as bleb formation or hypotony. Antibiotics and 
steroids were then injected into the remaining 1 quadrant of 
the subconjunctival space that was not served for sclerotomy. 
Examinations and follow-up 
Each patient underwent a thorough preoperative examination 
including Snellen visual acuity and applanation tonometry. 
Other ancillary tests such as fundus photography, optical 
coherence tomography, sonography, and fluorescein 
angiography were also performed if possible. Snellen visual 
acuity was converted into a logarithm of the minimum angle 
of resolution (LogMAR) score for analysis. The Wilcoxon 
signed rank test was used to compare the scores at the 
different postoperative periods. A p value of less than .05 
was considered to indicate statistical significance.
Patients were evaluated postoperatively using the same 
preoperative tests. Goldman applanation tonometry was 
performed on the operation day at 2 and 5 hours after 
surgery, and again at one day, 1 week, 1 month, and 3 
months postoperatively, and also at all follow-up visits after 
that period. Visual acuity was measured at 1 week, and 1, 
3, and 6 months postoperatively, and also at all follow-up 
visits after that period. In cases of gas tamponade, visual 
acuity measurement was performed after disappearance of the 
intraocular gas.
Results
The average patient age at the time of surgery was 61 
years (range, 41-74 years). Twelve patients were men. 
Twenty-two right eyes and 18 left eyes underwent surgery. 
The mean postoperative follow-up time was 8.4±3.4 months 
(range 3-13 months)
No complications were encountered with cannula use in 
any of the 40 eyes, nor was any slippage or loss of the 
cannula evident during scleral indentation for visualization of 
the retinal periphery.
Combined phacoemulsification and posterior chamber 
intraocular lens (IOL) implantation through clear corneal 
incision was performed in 23 eyes. All the cataract 
procedures were performed before the sclerotomy incisions 
were placed. A transient 10-0 nylon suture at clear cornea 
incision helped to prevent anterior chamber collapse during 
the cannula insertion procedure. There was no failure in 
cannula insertion due to hypotony or eye ball collapse. We 
didn't observe any IOL-related complications during the 
operation and postoperative follow-up periods. 
Intraoperative Suture placement was necessary in 3 eyes 
(7.5%). In one case of vitreous hemorrhage, sclerotomy of 
the dominant hand side was converted into a 20-gauge 
procedure to allow the use of 20-gauge endolaser probe due 
to impairment of the 23-gauge endolaser system. In one eye 
with Terson syndrome, leakage occurred at all 3 sclerotomy 
sites and in the other eye comprising vitreous hemorrhage 
with branched retinal vein occlusion, leakage occurred at the 
dominant hand site after vitrectomy.
Postoperative discomfort was reduced to a mild level as 
early as the first postoperative day in most cases and a much 
diminished traumatic external appearance was observed with 
the 23-gauge system compared with external photographs 
after vitrectomy with the 20-gauge system (Fig. 1).
The mean preoperative intraocular pressure (IOP) of all 40 
eyes was 12.0±2.7 mmHg (range: 7-19 mmHg) and 
postoperative IOP at 1 day, 1 week, and 1 month was 13.6±
3.7 mmHg (range: 8-24 mmHg), 13.2±6.0 mmHg (range: 
8-32 mmHg), and 12.4±5.0 mmHg (range: 7-24 mmHg), 
respectively.MJ Kim, et al. TRANSCONJUNCTIVAL SUTURELESS 23-GAUGE VITRECTOMY
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Fig. 1. Anterior segment photography of eyes after performing 20-gauge standard vitrectomy (A: postoperative 1 week, C: 
postoperative 6 weeks) and 23-gauge transconjunctival sutureless vitrectomy (B: postoperative 1 week, D: postoperative 6 weeks). 
Conjunctival injection and late scar formation were almost negligible in the external feature of the eyes that underwent 23-gauge TSV
(B,D). On the contrary, severe conjunctival injection (A) and late protruding healed scar were prominent in the eye that underwent
20-gauge vitrectomy (A,C).
Fig. 2. Preoperative and postoperative intraocular pressure 
changes at 2 hours, 5 hours, 1 day, 1 week, and 1 month. 
There were no significant differences in IOP among the 
measurements. No hypotony was observed after 1 
postoperative day in any of the 40 eyes. preop=preoperative;
h=hours; d=day; w=week; m=month.
Fig. 3. Visual acuity in logarithm of the minimal angle of 
resolution (LogMAR) units observed preoperatively and 
postoperatively at 1 week and 1, 3 and 6 months following 
surgery. Visual improvement was noted at 1 week and 1, 3 
and 6 months following 23-gauge transconjunctival sutureless 
vitrectomy (Wilcoxon signed rank test, P < .05).
Preop; preoperative, wk; week, mo; month.Kor J Ophthalmol Vol.21, No.4, 2007
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We also measured immediate postoperative IOP at 2 and 
5 hours after the surgery in 27 eyes. In these 27 eyes, the 
mean preoperative IOP was 11.9±2.6 mmHg (range: 7-17 
mmHg) and the mean IOPs at 2 and 5 hours were 12.6±5.9 
mmHg (range: 5-31 mmHg) and 13.8±5.1 mmHg (range: 
4-29 mmHg), respectively. In 1 (3.7%) of the 27 eyes, IOP 
was 5 mmHg at 2 hours and 4 mmHg at 5 hours, but it was 
normalized to 18 mmHg at 1 day after the surgery (Fig. 2).  
The median best corrected visual acuity (BCVA) improved 
from 20/400 (LogMAR, 1.21±0.63) preoperatively to 20/140 
(LogMAR, 0.83±0.48) at 1 week (p=0.003), 20/100 
(LogMAR, 0.85±0.65) at 1 month (p=0.002), 20/100 
(LogMAR, 0.73±0.6) at 3 months (p=0.001) and 20/100 
(LogMAR, 0.68±0.36) at 6 months postoperatively (p<0.0001) 
(Fig. 3).
During the follow-up period, no serious complications such 
as endophthalmitis or retinal detachment were detected. No 
patient developed sclerotomy-related complications (Table 1). 
Discussion
In this study, we applied the 23-gauge TSV technique to 
40 patients. Preoperative diagnoses were similar to those of 
previous series with 25- and 23-gauge systems including 
vitreous hemorrhage, diabetic macular edema, epiretinal 
membrane, and rhegmatogenous retinal detachment without 
PVR.
1-7 Eyes with both retinal detachment and PVR, severe 
tractional retinal detachment or those requiring silicone oil 
injection were excluded, as such cases are not generally 
recommended for a 25-gauge system.
4-6 Further study is 
therefore required to evaluate the appropriateness of using 
23-gauge vitrectomy for more complicated eyes.
When performing phacovitrectomy, many surgeons using 
25-gauge TSV suggest placement of microcannulas before 
cataract surgery to avoid introducing the microcannulas into 
a soft eye.
5,8 However, we performed phacovitrectomy 
without preplacement of microcannulas and found no 
problem in introducing 23-gauge microcannulas. A preformed 
tunnel incision with stiletto blade may reduce the resistance 
of the sclera against microcannula insertion, thus preventing 
eyeball deformity and instability of the cataract wound. So, 
preplacement of the microcannula before cataract surgery 
may no longer be recommendable in 23-gauge TSV.
Two (5%) of 40 eyes required suturing due to leakage 
after removal of cannulas. Lakhanpal et al
6 reported that 5 
among 140 cases which underwent 25-gauge TSV required 
suture placement due to leakage, and that the sutured site was 
near the surgeon's dominant hand, which did most of the 
intraocular manipulation. Because only 2 eyes required suture 
placement in this study, our study sample was too small to 
offer any support for such a trend.
In 25-gauge TSV, cases of early postoperative hypotony 
were firstly reported by Fujii et al.
2 O' Reilly et al.
5 reported 
transient hypotony in 10 of 39 cases (25.6%) and Lakhanpal 
et al.
6 reported that 2 out of 140 cases (1.4%) exhibited 
shallow choroidal detachments, which resolved in 1 week. 
However, there were no published data for immediate IOP 
changes within 1 day postoperatively in TSV. Therefore, we 
measured IOP at 2 and 5 hours after 23-gauge TSV in 27 
eyes. Only 1 eye (3.7%) showed hypotony (IOP≤5 mmHg) 
at 2 and 5 hours after surgery, which was normalized at 1 
day after the surgery. Because we observed localized blebs 
at the temporal side of the conjunctiva, the cause of hypotony 
may have been fluid leakage from the sclerotomy site. This 
bleb was completely resolved and IOP was normalized at 
postoperative day 1. No hypotony was observed at 
postoperative 1 day or after in any of the 40 eyes. This result 
is comparable to the report of Eckcardt
3 that no postoperative 
hypotony was observed in 41 eyes after 23-gauge TSV. 
However, immediate IOP data suggested that the tunnel-like 
incisions using stiletto blade did not completely guarantee the 
sealing of the sclerotomy wound. Fortunately, this transient 
hypotony did not show any complication during the 
follow-up periods. However, we need more cases and 
long-term follow-up to determine the effect of hypotony 
related with 23-gauge TSV.
Conjunctival injection and scarring were minimal with the 
23-gauge system, and the external appearance was much less 
traumatic than that with the 20-gauge system. As in 25-gauge 
TSV, 23-gauge self-sealing sclerotomy obviates the need for 
conjunctival peritomy and suturing, and also has the 
advantages of the minimally invasive, sutureless vitrectomy 
system. 
There is a concern that vitreous incarceration at the 
sclerotomy site might result in peripheral vitreous and retinal 
traction, and that the incidence of retinal detachment 
following 25-gauge TSV might be increased compared to that 
of standard 20-gauge surgery. Ibarra et al.
7 documented 
postoperative retinal detachment in one out of 45 consecutive 
eyes after 25-gauge vitrectomy and stated that the incidence 
of retinal detachment does not appear to be increased 
compared to that of standard 20-gauge surgery. Lakhanpal et 
al.
6 also reported no retinal detachment in their 140 
consecutive cases of 25-gauge TSV. During 8.4±3.4 months 
of follow-up, no cases of postoperative retinal detachment 
occurred in our series but long-term follow-up with a larger 
group is needed to determine the incidence of retinal 
detachment.  
We additionally did an in vitro experiment to evaluate the 
efficacy of 23-gauge infusion cannula and vitreous cutter 
following the method as described by Fujii et al.
1 To 
compare the effectiveness of the 23- (Reusable Infusion 
Cannula, 0.75 mm [23 G], DORC, Zuidland, Holland), 20- 
(BD Infusion Cannula, 4 mm, 0.90 mm [20 G], BD, 
Waltham, USA) and 25-gauge (25-gauge infusion cannula, 
Alcon Surgical, Texas, USA) infusion cannulas, we measured 
the time to infuse 10ml of balanced saline solution (BSS) at 
a bottle height of 40, 60, 80, 100 and 120 cm. We also 
measured the time to aspirate 5 ml of BSS with 20- (Accurus 
2500, Alcon Surgical, Texas, USA), 23- (Pneumatic MJ Kim, et al. TRANSCONJUNCTIVAL SUTURELESS 23-GAUGE VITRECTOMY
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Age (yrs) Sex Laterality Diagnosis Procedure Suture 
placement Preop VA Postop VA Follow-up
(months) Complication
41 F L DM TRD vit/mp/l none CF 20/400 6 none
61 F L DME vit/mp/cat none 20/200 20/70 17 none
72 F R DME vit/mp/cat none 20/400 20/400 10 none
61 F L DME vit/mp/l/cat none 20/300 20/100 3 none
63 F L DME vit/mp/l none 20/150 20/150 10 none
63 M R DME vit/mp/l none 20/150 20/150 3 none
67 F L DME vit/mp/cat none 20/70 20/30 3 none
52 F R DME vit/mp/cat none 20/200 20/70 9 none
58 F R DME vit/mp none 20/100 20/100 14 none
55 M R DME vit/mp none 20/150 20/100 6 none
63 F R DME vit/mp/l/g/cat none 20/200 20/150 6 none
63 F L ERM vit/mp/cat none 20/300 20/30 13 none
71 F L ERM vit/mp/cat none 20/200 20/50 11 none
68 F R ERM vit/mp none 20/50 20/800
* 10 Optic neuropathy
64 F L ERM vit/mp none 20/70 20/100 12 none
52 F R ERM vit/mp/l/cat none 20/800 20/150 7 none
72 M L ERM vit/mp/cat none 20/70 20/40 6 none
69 F L ERM vit/mp/g/cat none 20/70 20/50 8 none
64 F R MH vit/mp/g/cat none 20/400 20/200 8 unclosed MH
†
62 F R MH vit/mp/g/cat none 20/200 20/200 9 none
58 F R MH vit/mp/g/cat none 20/400 20/150 3 none
59 F R MH vit/mp/g/cat none 20/300 20/100 9 none
66 F L MH vit/mp/g/cat none 20/300 20/50 6 none
59 M L RD vit/mp/g none 20/50 20/30 8 none
39 F R VH vit/mp SN,ST,IT HM 20/25 10 none
69 M R VH vit/mp/l/cat none CF 20/50 6 none
49 M R VH vit/mp/l none HM 20/100 7 none
47 M L VH vit/mp/l SN 20/800 20/50 3 VH
58 F R VH vit/l none CF 20/20 4 none
73 F L VH vit/mp/l/cat ST LP 20/50 9 none
63 F L VH vit/mp/l none 20/50 20/50 7 none
71 M R VH vit/l/cat none 20/800 20/70 10 none
45 M R VH vit/mp/l none 20/800 20/50 11 none
63 M R VH vit/mp/l/g/cat none 20/800 20/300 6 MH developed
‡
68 M L VH vit/mp/l none 20/200 20/70 7 none
67 M R VMTS vit/mp/l/cat none 20/150 20/150 17 none
68 F R VMTS vit/mp none 20/150 20/150 10 none
47 F L VMTS vit/mp/cat none 20/400 20/150 3 none
67 F L VMTS vit/mp/cat none 20/100 20/40 8 none
74 F R VMTS vit/mp/l/cat none 20/100 20/40 8 none
F: female. M: male. ERM: epiretinal membrane. DME: diabetic macular edema. VH: vitreous hemorrhage. 
TRD: tractional retinal detachment. PDR: proliferetive diabetic retinopathy. MH: macular hole. RRD: 
rhegmatogenous retinal detachment. TS: Terson syndrome. BRVO: branched retinal vein occlusion. VMTS: 
vitreo-macular traction syndrome. Vit: vitrectomy. mp: membrane peeling. l: endolaser. g: intravitreal gas 
injection. cat: cataract extraction. SN: superonasal. ST: superotemporal. IT: inferotemporal. 
*Visual acuity 
decreased to 20/800 from 20/50 at 15 days after surgery due to the development of optic neuropathy of unknown 
origin. 
†This eye required a repeat vitrectomy for a reopened macular hole.
‡It was treated with argon laser 
photocoagulation with intravitreal gas injection.
Table 1. Clinical data of patients after 23-gauge TSV
Vitrectomy, 23-gauge, DORC, Zuidland, Holland) and 
25-gauge (Accurus 25-gauge, Alcon Surgical, Texas, USA) 
ocutomes by the aspiration setting of 100, 200, 300, 400, and 
500 mmHg using the same Accurus
Ⓡ Vitreoretinal Surgical 
System (Alcon Surgical, Texas, USA). Individual 
measurements were replicated 5 times to ensure reliability 
and reproducibility. In general, the average infusion rate of 
the 23-gauge cannula was 1.7- and 2.8-fold greater than that Kor J Ophthalmol Vol.21, No.4, 2007
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Fig. 4. Comparison among the infusion rates of balanced 
saline solution for 20-, 23- and 25-gauge infusion cannulas. 
The overall average infusion rate of the 23-gauge cannula was
1.7- and 2.8-fold greater than that of the 20- and 25-gauge 
cannulas, respectively.
Fig. 5. Comparison among the aspiration rates of balanced 
saline solution for 20-, 23- and 25-gauge ocutomes. The 
overall average aspiration rate of the 20-gauge ocutome was
3.2- and 5.9-fold greater than that of the 23- and 25-gauge 
ocutomes, respectively. The average aspiration rate of the 
23-gauge ocutome was 1.9-fold greater than that of the 
25-gauge ocutome. of the 20- and 25-gauge cannulas, respectively (Fig. 4) and 
the average aspiration rate of the 20-gauge ocutome was 3.2- 
and 5.9-fold greater than that of the 23- and 25-gauge 
ocutomes, respectively (Fig. 5). Although no controlled 
comparison study was performed in vivo, we can expect that 
the surgical time with the 23-gauge system might be at least 
the same as or less than that of the 25-gauge system. 
Although the inner diameter of 23- gauge cannula is smaller 
than that of 20-gauge system (0.65 mm vs. 0.80 mm), the 
infusion rate with the 23-gauge system was not only greater 
than that of the 25-gauge system, but also than that of the 
20-gauge system. We speculated that there would be a bottle 
neck effect in 20 gauge infusion system because, there is 
acute narrowing of inner diameter between infusion tube and 
infusion tip at the joint of the flange. In 23 G system, the 
infusion tube is directely connected to microcannula with 
funnel-shaped opening which may reduce bottle neck effect. 
Fujii et al.
2 insisted that the 25-gauge infusion cannula should 
not be used in conjunction with a 20-gauge vitreous cutter, 
because it may result in hypotony during aspiration resulting 
from the functional discrepancy between the infusion and 
aspiration rates of both systems. We could expect that no 
such concern will be necessary with the 23-gauge system. 
This study had some limitations. First, the relatively small 
sample size of this retrospective observational series and the 
relatively short-term follow-up were insufficient for 
meaningful conclusion regarding the efficacy and safety of 
the 23-gauge TSV. However, these promising results provide 
encouragement to conduct further prospective case series with 
a larger sample and longer follow-up. Second, we did not 
offer any information regarding the surgical time of 23-gauge 
TSV. We did not measure the precise procedure time, but, 
total procedure time is comparable to that of 20-gauge 
system. It is already known that the total procedure time of 
25-gauge TSV generally was not more than that of the 
20-gauge vitrectomy system in less complicated cases.
4,9 
Further study is needed to evaluate the precise surgical time 
depending on the step-by-step manner. Third, the surgeon's 
learning curve may affect the surgical results of 23-gauge 
TSV. Although the follow-up period was short and the 
sample was small, the study results confirmed a comparable 
surgical outcome and lack of severe complications. 
Considering that the 23-gauge TSV is a sturdier and more 
efficient instrument than the 25-gauge TSV, the effect of its 
learning curve may not be a major problem.
In conclusion, the 23-gauge sutureless vitrectomy 
technique was performed safely in cases of vitreous 
hemorrhage or tractional retinal detachment, epiretinal 
membrane, macular edema, macular hole and rhegmatogenous 
retinal detachment without PVR. The 23-gauge system 
features the potential benefits of being a sturdier and larger 
instrument than the 25-gauge TSV and we found that the 
infusion and aspiration rates were greater than those of the 
25-gauge TSV system. Further study is warranted to 
determine if procedures required for more extensive 
fibrovascular proliferation can be performed with this 
promising 23-gauge system.
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